FutureGen Industries Corp.

FutureGen Industries Corp.

LITT · V · Financial Services / Asset Management

0.07CAD+0.01 (+16.67%)

Price History

Full chart

Market Stats

Previous Close0.06
Open0.07
Day Range0.07 – 0.07
52-Week Range0.09 – 0.46
Volume19.00K
Market Cap5.01M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.09
Dividend Yield0.00%
Beta2.56
50-Day Avg0.1288
200-Day Avg0.2255

About

Right Season Investments Corp. is a venture capital, private equity and advisory firm specializing in incubation, seed, start-ups, later stage, strategic advisory, global partnership development, breakthrough products, devices, treatments, health supplement, corporate restructuring, Corporate recapitalization and growth capital investments. It focuses on managing and facilitating foreign investment and investing in private and public companies whose businesses involve later-stage. The firm prefers to invest in health & wellness, agricultural, medicinal mushroom, media, retail, financial services, pharmaceutical products, nutrition, medicine, technology, healthcare, clean tech, energy, consumer product, and consumer services and identify an exit strategy in China or North America. The firm invests into companies across the Pan-Pacific region. It prefers to take majority stake in its portfolio companies. Right Season Investments Corp. was formerly known as Roadman Investments Corp. Right Season Investments Corp. was incorporated in September 2007 and is based in Vancouver, Canada with an additional office in Beijing, China.

Company Details

  • SectorFinancial Services
  • IndustryAsset Management
  • CEODr. Kristian Thorlund MSc, Ph.D.
  • Employees0
  • Headquarters800-1199 West Hastings Street, Vancouver, BC, Canada, V6E 3T5, Canada
  • Websitehttps://www.rightseasoninvestmentscorp.com

Leadership

  • Dr. Kristian Thorlund MSc, Ph.D.CEO & Director · b. 1981
  • Mr. Tyler LewisInterim CFO, Interim Corporate Secretary & Director
  • Mr. Kevin SorochanLegal Counsel
  • Mr. Larry YenCorporate Secretary
  • Wang WeiInvestment Partner
  • Dr. Timothy SzeInvestment Director
  • Ning JianInvestment Director
  • Edward LuInvestment Director
  • Vincent WangInvestment Director
  • Michael JingInvestment Director

Financials

Income Statement

Currency: CAD2008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Total Revenue-2.32K613.34K-1.32M995.25K346.76K-214.41K-110.82K44.60K102.22K90.20K-2.05M-783.06K686.30K155.04K110.64K-426.84K795.75K
Growth (%)--+26382.77%-315.97%+175.14%-65.16%-161.83%+48.31%+140.25%+129.19%-11.76%-2369.35%+61.75%+187.64%-77.41%-28.64%-485.81%+286.43%
Cost of Revenue----1.69M----46.57K39.95K85.47K2.02K704----
Gross Profit-2.32K613.34K-1.32M-691.68K346.76K-214.41K-110.82K44.60K55.65K50.26K-2.13M-785.08K685.60K155.04K110.64K--
Gross Margin-100.00%100.00%100.00%-69.50%100.00%100.00%100.00%100.00%54.44%55.71%104.18%100.26%99.90%100.00%100.00%--
Operating Expense-97.29K551.43K726.37K604.34K434.54K602.34K510.07K644.44K839.36K555.48K1.52M1.93M3.16M2.86M-8.96K--
Operating Income-102.37K-94.97K61.91K-2.05M-1.30M-87.79K-816.74K-620.89K-599.84K-783.71K-505.22K-3.66M-2.71M-2.48M-2.71M119.60K-1.48M-1.49M
Operating Margin--4100.78%10.09%154.84%-130.22%-25.32%380.93%560.29%-1344.90%-766.68%-560.10%178.58%346.28%-361.02%-1747.20%108.10%346.72%-187.66%
EBITDA-102.37K-94.97K73.44K-2.04M-1.28M-59.11K-773.10K-622.45K-587.52K-750.49K-503.46K-3.65M-2.71M-2.48M-2.71M119.60K-1.77M-1.63M
EBITDA Margin--4100.78%11.97%153.89%-128.63%-17.05%360.58%561.69%-1317.29%-734.17%-558.15%178.47%346.02%-360.92%-1747.20%108.10%414.78%-205.39%
Net Income-101.47K-94.97K62.98K-2.05M-1.24M-75.95K-855.07K-618.04K-597.43K-616.50K-203.00K-4.16M-2.69M-2.59M-2.66M342.50K-1.77M-1.64M
Net Income Margin--4100.78%10.27%154.79%-124.11%-21.90%398.81%557.72%-1339.51%-603.10%-225.05%203.29%343.70%-377.61%-1717.04%309.57%414.78%-205.63%
R&D------------0300.23K145.89K---
R&D as % of Total Revenue------------0.00%43.75%94.10%---
Interest Expense--10.45K3.10K10.62K410-011.25K31.27K23.24K11.98K2.61K17.95K1.27K10001.94K
Interest Expense % of Total Revenue--1.70%-0.23%1.07%0.12%-0.00%25.23%30.59%25.76%-0.59%-0.33%2.61%0.82%0.09%0.00%0.24%

Balance Sheet

Currency: CAD2008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Total Assets303.79K233.56K4.91M2.89M1.58M1.24M1.42M800.16K780.32K234.47K353.74K759.53K341.74K2.92M818.64K7.52M5.91M4.33M
Total Liabilities32.81K57.56K301.52K330.13K303.06K29.43K64.36K55.68K633.28K730.23K716.20K408.88K482.40K423.13K829.37K639.70K790.12K789.61K
Total Equity270.98K176.00K4.61M2.56M1.27M1.21M1.36M744.48K147.05K-469.45K-336.65K376.71K-114.25K2.53M15.68K6.91M5.14M3.54M
Cash301.02K227.91K1.60M131.54K539.29K308.48K607.49K140.63K150.75K49.67K227.25K316.53K81.79K1.01M111.68K166.70K178.37K25.51K
Total Debt--263.75K312.73K252.17K---600.00K658.50K347.82K88.50K13.50K13.50K183.50K183.50K--
Net Debt-301.02K-227.91K-1.34M181.19K-287.13K-308.48K-607.49K-140.63K449.25K608.83K120.57K-228.03K-68.29K-997.91K71.82K16.80K5.13K263.44K

Cash Flow

Currency: CAD2008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Operating Cash Flow-22.06K-73.11K-471.44K-707.16K-415.69K-64.89K-569.74K-212.72K-252.40K-483.69K-99.28K-1.07M-1.42M-1.99M-755.12K-847.92K-962.32K-931.94K
Investing Cash Flow--------204.14K139.39K313.37K-25.00K-17.12K131.29K-622.47K-338.61K-5.34M--
Financing Cash Flow323.08K-2.55M48.63K-61.39K-252.17K950.00K-50.00K123.12K69.25K301.86K1.17M1.06M3.54M194.00K6.24M0117.00K
Capital Expenditure00016.91K8422.24K60.00K3.19K4.99K4.99K2.12K2.12K000000
Free Cash Flow-22.06K-73.11K-471.44K-724.08K-416.54K-67.14K-629.74K-215.91K-252.40K-488.68K-99.28K-1.07M-1.42M-1.99M-755.12K-847.92K-962.32K-931.94K
FCF to OCF100.00%100.00%100.00%102.39%100.20%103.45%110.53%101.50%100.00%101.03%100.00%100.20%100.00%100.00%100.00%100.00%100.00%100.00%

Earnings

Report DateSep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Oct 28, 2026
EPS Estimate---------------------------
EPS Actual-0.02-0.01-0.04-0.080.01-0.000.05-0.09-0.03-0.06-0.12-0.31-0.11-0.02-0.03-0.08-0.02-0.01-0.11-0.03-0.04-0.03-0.02-0.020.000.02-
Surprise---------------------------
Timing--------------------------After-hours

Key Statistics & Ratios

Market Cap5.01M
Enterprise Value2.89M
Trailing P/E0.00
Forward P/E0.00
Price / Sales6.25
Price / Book3.07
EPS-0.09
Book Value0.034
Revenue (TTM)1.21K
Gross Profit (TTM)-126.00K
EBITDA-1.55M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-131.42%
Return on Assets-23.74%
Shares Outstanding55.61M
Shares Float53.28M
Beta2.56
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Aug 21, 202515:1
  • Oct 30, 20231:70
  • Jan 24, 20221:10